Home » Abbott Completes Acquisition of Ibis Biosciences
Abbott Completes Acquisition of Ibis Biosciences
Isis Pharmaceuticals, Inc. and Abbott announced that Abbott has completed its purchase of Ibis Biosciences, Inc., an Isis subsidiary, for a closing purchase price of $175 million.
SunHerald.com
SunHerald.com
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May